Literature DB >> 7199348

Syncope in hypertrophic cardiomyopathy.

W McKenna, L Harris, J Deanfield.   

Abstract

A patient with hypertrophic cardiomyopathy, syncope, and frequent ventricular tachycardia was monitored during a syncopal episode. An unrecordable blood pressure and the loss of a left ventricular outflow tract murmur without evidence of arrhythmia suggested a primary haemodynamic mechanism such as reduction in left ventricular volume.

Entities:  

Mesh：

Year:  1982        PMID： 7199348      PMCID： PMC481117          DOI： 10.1136/hrt.47.2.177

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  9 in total

1.  Prognosis and mortality of hypertrophic obstructive cardiomyopathy.

Authors:  T Hardarson; C S De la Calzada; R Curiel; J F Goodwin
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

2.  Syncope in hypertrophic obstructive cardiomyopathy due to asystole.

Authors:  S Joseph; R Balcon; L McDonald
Journal:  Br Heart J       Date:  1972-09

3.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Authors:  D R Rosing; K M Kent; B J Maron; S E Epstein
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

4.  Complete heart block as a cause of syncope in asymmetric septal hypertrophy.

Authors:  C A Chmielewski; R S Riley; A Mahendran; A S Most
Journal:  Am Heart J       Date:  1977-01       Impact factor: 4.749

5.  Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

Authors:  W J McKenna; L Harris; G Perez; D M Krikler; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

6.  Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy.

Authors:  J F Goodwin; D M Krikler
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

7.  Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways.

Authors:  D M Krikler; M J Davies; E Rowland; J F Goodwin; R C Evans; D B Shaw
Journal:  Br Heart J       Date:  1980-03

8.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

9.  Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778
  9 in total
  3 in total

Review 1.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

2.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

3.  Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making.

Authors:  Milena Leo; Alexander J Sharp; Andre Briosa E Gala; Michael T B Pope; Timothy R Betts
Journal:  J Interv Card Electrophysiol       Date:  2022-07-14       Impact factor: 1.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.